Skip to main content
Log in

Zollinger-Ellison syndrome, antisecretory treatment, and body weight

  • Letters to the Editor
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Frucht H, Maton PN, Jensen RT: Use of Omeprazole in patients with Zollinger-Ellison syndrome. Dig Dis Sci 36:394–404, 1991

    Google Scholar 

  2. Dourish CT, Rycroft W, Iversen SD: Postponement of satiety by blockade of brain cholecystokinin (CCK-B) receptors. Science 245:1509–1511, 1989

    Google Scholar 

  3. Geracioti TD, Liddte RA: Impaired cholecystokinin secretion in bulimia nervosa. N Engl J Med 319:683–688, 1988

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Raoul, J.L., Bretagne, J.F., Ropert, A. et al. Zollinger-Ellison syndrome, antisecretory treatment, and body weight. Digest Dis Sci 37, 1308–1309 (1992). https://doi.org/10.1007/BF01296581

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01296581

Keywords

Navigation